Peter Riegman

5.6k total citations · 1 hit paper
70 papers, 3.8k citations indexed

About

Peter Riegman is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Peter Riegman has authored 70 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 14 papers in Genetics and 14 papers in Cancer Research. Recurrent topics in Peter Riegman's work include Molecular Biology Techniques and Applications (19 papers), Cancer Genomics and Diagnostics (11 papers) and Ethics in Clinical Research (11 papers). Peter Riegman is often cited by papers focused on Molecular Biology Techniques and Applications (19 papers), Cancer Genomics and Diagnostics (11 papers) and Ethics in Clinical Research (11 papers). Peter Riegman collaborates with scholars based in Netherlands, Italy and Austria. Peter Riegman's co-authors include Jan Trapman, R.J. Vlietstra, J.A.G.M. van der Korput, Albert O. Brinkmann, Manuel M. Morente, J.C. Romijn, Jun Hou, Henk C. Hoogsteden, Sjaak Philipsen and John A. Foekens and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Peter Riegman

68 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gene Expression-Based Classification of Non-Small Cell Lung Carcinomas and Survival Prediction

2010 614 citations Jun Hou, Joachim G.J.V. Aerts et al. PLoS ONE profile →

Peers

Countries citing papers authored by Peter Riegman

Since Specialization

Citations

This map shows the geographic impact of Peter Riegman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Riegman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Riegman more than expected).

Fields of papers citing papers by Peter Riegman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Riegman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Riegman. The network helps show where Peter Riegman may publish in the future.

Co-authorship network of co-authors of Peter Riegman

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Riegman. A scholar is included among the top collaborators of Peter Riegman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Riegman. Peter Riegman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cryo-Gel embedding compound for renal biopsy biobanking 2019 ·Scientific Reports ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Thierry van den Bosch, Lennard J. M. Dekker, Michail Doukas, Theo M. Luider, Peter Riegman, Folkert J. van Kemenade, Marian C. Clahsen‐van Groningen	5
2	A Review of International Biobanks and Networks: Success Factors and Key Benchmarks—A 10-Year Retrospective Review 2019 ·Biopreservation and Biobanking ·(unknown), Lisa Devereux, Peter H. Watson, Anne‐Marie Mes‐Masson, (unknown), (unknown), (unknown), Valerie Speirs, Andrew G. Hall, (unknown), Manuel Posada de la Paz, Hanns Lochmüller, Heather Thorne, (unknown), Peter Riegman, Wayne Ng, (unknown)	8
3	Pre-analytical processes in medical diagnostics: New regulatory requirements and standards 2019 ·New Biotechnology ·Georges Dagher, Karl‐Friedrich Becker, Serena Bonin, Carole A. Foy, Stefania Gelmini, Mikael Kubista, (unknown), (unknown), Helen Parkes, Pamela Pinzani, Peter Riegman, Ulrike Schröder, Cornelia Stumptner, Paola Turano, Robert Sjöback, Andrea Wutte, Kurt Zatloukal	30
4	Personalised Medicine - Bringing Innovation to the Healthcare System 2017 ·PubMed ·Denis Horgan, Mary Baker, Peter Riegman, (unknown)	1
5	Accelerating the Development and Validation of New Value-Based Diagnostics by Leveraging Biobanks 2016 ·Public Health Genomics ·Daniel J. Schneider, Peter Riegman, Maureen Cronin, Anastassia Negrouk, Holger Moch, Rudi Balling, F Penault–Llorca, Kurt Zatloukal, Denis Horgan	5
6	The Influence of Tissue Procurement Procedures on RNA Integrity, Gene Expression, and Morphology in Porcine and Human Liver Tissue 2015 ·Biopreservation and Biobanking ·Marcel Kap, Anieta M. Sieuwerts, Mikael Kubista, (unknown), (unknown), Peter Riegman	20
7	Fit for Purpose Frozen Tissue Collections by RNA Integrity Number-Based Quality Control Assurance at the Erasmus MC Tissue Bank 2014 ·Biopreservation and Biobanking ·Marcel Kap, (unknown), (unknown), Bas de Jong, Peter Riegman	41
8	Inactivation of Influenza A virus , Adenovirus, and Cytomegalovirus with PAXgene Tissue Fixative and Formalin 2013 ·Biopreservation and Biobanking ·Marcel Kap, (unknown), Martina Loibner, (unknown), (unknown), Kurt Zatloukal, Jean‐Luc Murk, Peter Riegman	9
9	Annual Conferences of the European, Middle Eastern and African Society for Biopreservation and Biobanking (ESBB): Overview of 2011 and Preview of 2012 2012 ·Biopreservation and Biobanking ·Christian Chabannon, Peter Doran, Paul Hofman, Ole Seberg, (unknown), Marianna J. Bledsoe, Hans‐Peter Deigner, Jan Koschorreck, Georges Dagher, Ann Cooreman, Pasquale De Blasio, Peter Riegman, Robert E. Hewitt	1
10	Concluding Remarks: “Biobanking for Cancer Research: Rules and Roles,” November 2010, Bari, Italy 2011 ·Biopreservation and Biobanking ·Peter Riegman, Maria Grazia Daidone, Angelo Paradiso	1
11	What are Some Top Accomplishments You Would Like to See in the Field by 2015? 2011 ·Biopreservation and Biobanking ·Stella Somiari, Peter Riegman, Manuel M. Morente, John M. Baust, Glyn Stacey	2
12	Biospecimen reporting for improved study quality (BRISQ) 2011 ·Cancer Cytopathology ·Helen M. Moore, Andréa B. Kelly, Scott D. Jewell, Lisa M. McShane, Douglas P. Clark, (unknown), Daniel F. Hayes, Pierre Hainaut, Paula Kim, Elizabeth Mansfield, Olga Potapova, Peter Riegman, Yaffa Rubinstein, Edward Seijo, Stella Somiari, Peter H. Watson, (unknown), Claire S. Zhu, Jim Vaught	129
13	Introduction to Cancer Biobanking: Why, Where, How? 2011 ·Biopreservation and Biobanking ·Angelo Paradiso, Maria Grazia Daidone, Peter Riegman	0
14	Gene Expression-Based Classification of Non-Small Cell Lung Carcinomas and Survival Prediction breakdown → 2010 ·PLoS ONE ·Jun Hou, Joachim G.J.V. Aerts, Bianca den Hamer, Wilfred F. J. van IJcken, Michael den Bakker, Peter Riegman, Cor van der Leest, Peter J. van der Spek, John A. Foekens, Henk C. Hoogsteden, Frank Grosveld, Sjaak Philipsen	614
15	Pathology as the Cornerstone of Human Tissue Banking: European Consensus Expert Group Report 2009 ·Biopreservation and Biobanking ·Pierre Hainaut, Élodie Caboux, Generoso Bevilacqua, (unknown), (unknown), Heinz Hoefler, Anne Janin, Rupert Langer, Denis Larsimont, Manuel M. Morente, Peter Riegman, Peter Schirmacher, Giorgio Stanta, Kurt Zatloukal	15
16	The NF2 protein co-localizes with elements of the cytoskeleton 1995 ·American Journal Of Pathology ·Marinka A.H. Bakker, (unknown), Peter Riegman, (unknown), W.J.A. Boersma, P. J. A. Janssen, (unknown), Wiljan Hendriks, Theodorus van der Kwast, Ellen C. Zwarthoff	1
17	Cytogenetic, Molecular Genetic and Pathological Analyses in 126 Meningiomas 1995 ·Journal of Neuropathology & Experimental Neurology ·(unknown), Peter Riegman, (unknown), (unknown), Nicole A. Groen, S Stefanko, (unknown), C. J. J. Avezaat, (unknown), (unknown)	88
18	Identification and androgen-regulated expression of two major human glandular kallikrein-1 (hGK-1) mRNA species 1991 ·Molecular and Cellular Endocrinology ·Peter Riegman, R.J. Vlietstra, Hetty A. G. M. van der Korput, (unknown), Jan Trapman	75
19	The prostate‐specific antigen gene and the human glandular kallikrein‐1 gene are tandemly located on chromosome 19 1989 ·FEBS Letters ·Peter Riegman, R.J. Vlietstra, Paul Klaassen, J.A.G.M. van der Korput, Ad Geurts van Kessel, J.C. Romijn, Jan Trapman	64
20	Molecular cloning and characterization of novel prostate antigen cDNA's 1988 ·Biochemical and Biophysical Research Communications ·Peter Riegman, Paul Klaassen, J.A.G.M. van der Korput, J.C. Romijn, Jan Trapman	87

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact